CureDiab at EASL congress in Barcelona

22. Mai 2026

From 27th-30th of May we will join the EASL congress in Barcelona. We will present our latest discovery about the multifaceted effects of our positive allosteric modulators of the GABA-A receptor. We are looking forward to join interesting talks and discuss about the updates on drug development for MASLD. Do not hesitate to contact us and meet us there.